Tapewire

Nasdaq · USD

TNGX

Tango Therapeutics, Inc.

Export transactions ↓
Tapewire entity
1497
SEC CIK
0001819133
Parsed reports
150

Last 12 months

Inside the activity.

0 purchase rows · 25 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202607
Mar 202602
Apr 202602
May 202602
Jun 202602
Jul 202602
Aug 202602
Sep 202604
Oct 202602

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 25, 2026 Filed Feb 27, 2026 23:54 UTC
Crystal AdamPresident, R&D
SaleCommon Stock 54,345 $12.77 $694,208.46
Disclosure

SEC source: 0001193125-26-083579 · ownership.xml · nonDerivative · entry 1

Crystal Adam · CIK 0001825445 · President, R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 132,873

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 27, 2025.

F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $12.61 to $13.09 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

Read SEC document
February 03, 2026 Filed Feb 5, 2026 01:12 UTC
Beckman DaniellaChief Financial Officer
SaleCommon Stock 113 $12.90 $1,457.37
Disclosure

SEC source: 0001193125-26-038072 · ownership.xml · nonDerivative · entry 3

Beckman Daniella · CIK 0001513422 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 184,297

F2 · kind: The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $12.88 to $12.91 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

Read SEC document
February 03, 2026 Filed Feb 5, 2026 01:12 UTC
Beckman DaniellaChief Financial Officer
SaleCommon Stock 10,204 $12.26 $125,073.49
Disclosure

SEC source: 0001193125-26-038072 · ownership.xml · nonDerivative · entry 2

Beckman Daniella · CIK 0001513422 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 184,410

F2 · kind: The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $11.88 to $12.875 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

Read SEC document
February 03, 2026 Filed Feb 5, 2026 01:09 UTC
Weber BarbaraDirector · Director, Executive Chair
SaleCommon Stock 333 $12.90 $4,294.73
Disclosure

SEC source: 0001193125-26-038070 · ownership.xml · nonDerivative · entry 3

Weber Barbara · CIK 0001800670 · Director · Director, Executive Chair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,629,254

F2 · kind: The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $12.88 to $12.91 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

Read SEC document
February 03, 2026 Filed Feb 5, 2026 01:09 UTC
Weber BarbaraDirector · Director, Executive Chair
SaleCommon Stock 30,186 $12.26 $369,998.86
Disclosure

SEC source: 0001193125-26-038070 · ownership.xml · nonDerivative · entry 2

Weber Barbara · CIK 0001800670 · Director · Director, Executive Chair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,629,587

F2 · kind: The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $11.88 to $12.875 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

Read SEC document
February 03, 2026 Filed Feb 5, 2026 01:02 UTC
Crystal AdamPresident, R&D
SaleCommon Stock 201 $12.90 $2,592.32
Disclosure

SEC source: 0001193125-26-038052 · ownership.xml · nonDerivative · entry 3

Crystal Adam · CIK 0001825445 · President, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 187,218

F2 · kind: The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $12.88 to $12.91 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

Read SEC document
February 03, 2026 Filed Feb 5, 2026 01:02 UTC
Crystal AdamPresident, R&D
SaleCommon Stock 18,251 $12.26 $223,707.98
Disclosure

SEC source: 0001193125-26-038052 · ownership.xml · nonDerivative · entry 2

Crystal Adam · CIK 0001825445 · President, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 187,419

F2 · kind: The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $11.88 to $12.875 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

Read SEC document
February 02, 2026 Filed Feb 5, 2026 01:12 UTC
Beckman DaniellaChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 265,980 $0.00 Strike: $11.94 $0.00
Disclosure

SEC source: 0001193125-26-038072 · ownership.xml · derivative · entry 4

Beckman Daniella · CIK 0001513422 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 265,980

Underlying: Common Stock · 265,980 shares

Expires 2036-02-02

F5 · derivative.exercise_date: This option shall vest and become exercisable over a four-year period, at a rate of 25% on January 1, 2027 with the remaining option shares vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

Read SEC document
February 02, 2026 Filed Feb 5, 2026 01:12 UTC
Beckman DaniellaChief Financial Officer
GrantCommon Stock 44,330 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-038072 · ownership.xml · nonDerivative · entry 1

Beckman Daniella · CIK 0001513422 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 194,614

F1 · shares: These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest over a three year period at a rate of 33% on February 1, 2027, 33% on February 14, 2028 and 34% on February 12, 2029, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

Read SEC document
February 02, 2026 Filed Feb 5, 2026 01:09 UTC
Weber BarbaraDirector · Director, Executive Chair
GrantStock Option (Right to Buy) · Derivative 222,132 $0.00 Strike: $11.94 $0.00
Disclosure

SEC source: 0001193125-26-038070 · ownership.xml · derivative · entry 4

Weber Barbara · CIK 0001800670 · Director · Director, Executive Chair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 222,132

Underlying: Common Stock · 222,132 shares

Expires 2036-02-02

F5 · derivative.exercise_date: This option shall vest and become exercisable in 12 equal monthly installments following January 1, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

Read SEC document
February 02, 2026 Filed Feb 5, 2026 01:09 UTC
Weber BarbaraDirector · Director, Executive Chair
GrantCommon Stock 37,522 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-038070 · ownership.xml · nonDerivative · entry 1

Weber Barbara · CIK 0001800670 · Director · Director, Executive Chair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,659,773

F1 · shares: These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in full on February 1, 2027, subject to the Reporting Person's continuous service with the Issuer as of such vesting date.

Read SEC document
February 02, 2026 Filed Feb 5, 2026 01:02 UTC
Crystal AdamPresident, R&D
GrantStock Option (Right to Buy) · Derivative 284,760 $0.00 Strike: $11.94 $0.00
Disclosure

SEC source: 0001193125-26-038052 · ownership.xml · derivative · entry 4

Crystal Adam · CIK 0001825445 · President, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 284,760

Underlying: Common Stock · 284,760 shares

Expires 2036-02-02

F5 · derivative.exercise_date: This option shall vest and become exercisable over a four-year period, at a rate of 25% on January 1, 2027 with the remaining option shares vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

Read SEC document
February 02, 2026 Filed Feb 5, 2026 01:02 UTC
Crystal AdamPresident, R&D
GrantCommon Stock 47,460 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-038052 · ownership.xml · nonDerivative · entry 1

Crystal Adam · CIK 0001825445 · President, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 205,670

F1 · shares: These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest over a three year period at a rate of 33% on February 1, 2027, 33% on February 14, 2028 and 34% on February 12, 2029, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

Read SEC document
January 08, 2026 Filed Jan 12, 2026 11:15 UTC
Peters MalteDirector · President & CEO
GrantStock Option (Right to Buy) · Derivative 1,650,000 $0.00 Strike: $11.06 $0.00
Disclosure

SEC source: 0001193125-26-009663 · ownership.xml · derivative · entry 2

Peters Malte · CIK 0001876563 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,650,000

Underlying: Common Stock · 1,650,000 shares

Expires 2036-01-08

F2 · derivative.exercise_date: This option shall vest and become exercisable over a four-year period, with 25% vesting on January 8, 2027 and the remaining option shares vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

Read SEC document
January 08, 2026 Filed Jan 12, 2026 11:15 UTC
Peters MalteDirector · President & CEO
GrantCommon Stock 350,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-009663 · ownership.xml · nonDerivative · entry 1

Peters Malte · CIK 0001876563 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 367,500

F1 · shares: These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest over a three year period at a rate of 33% on February 1, 2027, 33% on February 14, 2028 and 34% on February 12, 2029, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 21:10 UTC
Lee SungDirector
GrantStock Option (Right to Buy) · Derivative 60,000 $0.00 Strike: $8.93 $0.00
Disclosure

SEC source: 0001193125-26-004433 · ownership.xml · derivative · entry 2

Lee Sung · CIK 0001793200 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2036-01-02

F2 · derivative.exercise_date: This option shall vest and become exercisable in 36 substantially equal monthly installments over a period of three years following the grant date, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 21:10 UTC
Lee SungDirector
GrantCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-004433 · ownership.xml · nonDerivative · entry 1

Lee Sung · CIK 0001793200 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

F1 · shares: These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in three substantially equal annual installments following the grant date, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

Read SEC document
November 03, 2025 Filed Nov 4, 2025 14:25 UTC
Peters MalteDirector
GrantStock Option (Right to Buy) · Derivative 150,000 $0.00 Strike: $8.01 $0.00
Disclosure

SEC source: 0001193125-25-263710 · ownership.xml · derivative · entry 1

Peters Malte · CIK 0001876563 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2035-11-03

F1 · derivative.exercise_date: This option shall vest and become exercisable in 48 substantially equal monthly installments over a period of four years, with the first vesting date on December 3, 2025, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

Read SEC document
October 23, 2025 Filed Oct 27, 2025 20:15 UTC SaleCommon Stock 477,401 $10.15 $4,846,574.95
Disclosure

SEC source: 0001193125-25-251606 · ownership.xml · nonDerivative · entry 1

Third Rock Ventures IV, L.P. · CIK 0001688327 · 10% owner

Third Rock Ventures GP IV, L.P. · CIK 0001688326 · 10% owner

TRV GP IV, LLC · CIK 0001688325 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,386,574

F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.65, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).

F2 · ownership.direct: These shares are directly held by Third Rock Ventures IV, L.P. ("TRV IV"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. ("TRV GP IV"). The general partner of TRV GP IV is TRV GP IV, LLC ("TRV GP IV LLC"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares.

Read SEC document
September 25, 2025 Filed Sep 29, 2025 20:15 UTC SaleCommon Stock 500,000 $8.02 $4,008,500.00
Disclosure

SEC source: 0001193125-25-223227 · ownership.xml · nonDerivative · entry 1

Third Rock Ventures IV, L.P. · CIK 0001688327 · 10% owner

Third Rock Ventures GP IV, L.P. · CIK 0001688326 · 10% owner

TRV GP IV, LLC · CIK 0001688325 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,863,975

F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.00 to $8.165, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).

F2 · ownership.direct: These shares are directly held by Third Rock Ventures IV, L.P. ("TRV IV"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. ("TRV GP IV"). The general partner of TRV GP IV is TRV GP IV, LLC ("TRV GP IV LLC"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares.

Read SEC document
September 16, 2025 Filed Sep 17, 2025 22:06 UTC SaleCommon Stock 363,541 $7.04 $2,559,328.64
Disclosure

SEC source: 0001193125-25-206453 · ownership.xml · nonDerivative · entry 1

Third Rock Ventures IV, L.P. · CIK 0001688327 · 10% owner

Third Rock Ventures GP IV, L.P. · CIK 0001688326 · 10% owner

TRV GP IV, LLC · CIK 0001688325 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,363,975

F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.19, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).

F2 · ownership.direct: These shares are directly held by Third Rock Ventures IV, L.P. ("TRV IV"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. ("TRV GP IV"). The general partner of TRV GP IV is TRV GP IV, LLC ("TRV GP IV LLC"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares.

Read SEC document
September 08, 2025 Filed Sep 9, 2025 20:15 UTC SaleCommon Stock 86,459 $7.04 $608,628.13
Disclosure

SEC source: 0001193125-25-199177 · ownership.xml · nonDerivative · entry 2

Third Rock Ventures IV, L.P. · CIK 0001688327 · 10% owner

Third Rock Ventures GP IV, L.P. · CIK 0001688326 · 10% owner

TRV GP IV, LLC · CIK 0001688325 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,727,516

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).

F1 · ownership.direct: These shares are directly held by Third Rock Ventures IV, L.P. ("TRV IV"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. ("TRV GP IV"). The general partner of TRV GP IV is TRV GP IV, LLC ("TRV GP IV LLC"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares.

Read SEC document
September 05, 2025 Filed Sep 9, 2025 20:15 UTC SaleCommon Stock 642,906 $7.00 $4,500,342.00
Disclosure

SEC source: 0001193125-25-199177 · ownership.xml · nonDerivative · entry 1

Third Rock Ventures IV, L.P. · CIK 0001688327 · 10% owner

Third Rock Ventures GP IV, L.P. · CIK 0001688326 · 10% owner

TRV GP IV, LLC · CIK 0001688325 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,813,975

F1 · ownership.direct: These shares are directly held by Third Rock Ventures IV, L.P. ("TRV IV"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. ("TRV GP IV"). The general partner of TRV GP IV is TRV GP IV, LLC ("TRV GP IV LLC"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares.

Read SEC document
August 22, 2025 Filed Aug 26, 2025 20:15 UTC SaleCommon Stock 302,194 $7.00 $2,115,358.00
Disclosure

SEC source: 0000950170-25-111457 · ownership.xml · nonDerivative · entry 1

Third Rock Ventures IV, L.P. · CIK 0001688327 · 10% owner

Third Rock Ventures GP IV, L.P. · CIK 0001688326 · 10% owner

TRV GP IV, LLC · CIK 0001688325 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,456,881

F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).

F2 · ownership.direct: These shares are directly held by Third Rock Ventures IV, L.P. ("TRV IV"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. ("TRV GP IV"). The general partner of TRV GP IV is TRV GP IV, LLC ("TRV GP IV LLC"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares.

Read SEC document
August 19, 2025 Filed Aug 21, 2025 20:15 UTC SaleCommon Stock 1,100,000 $7.01 $7,712,760.00
Disclosure

SEC source: 0000950170-25-110662 · ownership.xml · nonDerivative · entry 1

Third Rock Ventures IV, L.P. · CIK 0001688327 · 10% owner

Third Rock Ventures GP IV, L.P. · CIK 0001688326 · 10% owner

TRV GP IV, LLC · CIK 0001688325 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,759,075

F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).

F2 · ownership.direct: These shares are directly held by Third Rock Ventures IV, L.P. ("TRV IV"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. ("TRV GP IV"). The general partner of TRV GP IV is TRV GP IV, LLC ("TRV GP IV LLC"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares.

Read SEC document
June 05, 2025 Filed Jun 9, 2025 21:51 UTC
Peters MalteDirector
GrantStock Option (Right to Buy) · Derivative 37,500 $0.00 Strike: $3.51 $0.00
Disclosure

SEC source: 0000950170-25-083912 · ownership.xml · derivative · entry 2

Peters Malte · CIK 0001876563 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 37,500 shares

Expires 2035-06-05

F2 · derivative.exercise_date: This option shall vest and become exercisable in 12 substantially equal monthly installments over a period of one year, with the first vesting date on July 5, 2025, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

Read SEC document
June 05, 2025 Filed Jun 9, 2025 21:51 UTC
Peters MalteDirector
GrantCommon Stock 6,250 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-083912 · ownership.xml · nonDerivative · entry 1

Peters Malte · CIK 0001876563 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,500

F1 · shares: These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in its entirety on the earlier of: (i) June 5, 2026 and (ii) the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

Read SEC document
June 05, 2025 Filed Jun 9, 2025 21:50 UTC GrantStock Option (Right to Buy) · Derivative 37,500 $0.00 Strike: $3.51 $0.00
Disclosure

SEC source: 0000950170-25-083911 · ownership.xml · derivative · entry 2

Calhoun Lesley Ann · CIK 0001730866 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 37,500 shares

Expires 2035-06-05

F2 · derivative.exercise_date: This option shall vest and become exercisable in 12 substantially equal monthly installments over a period of one year, with the first vesting date on July 5, 2025, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

Read SEC document
June 05, 2025 Filed Jun 9, 2025 21:50 UTC GrantCommon Stock 6,250 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-083911 · ownership.xml · nonDerivative · entry 1

Calhoun Lesley Ann · CIK 0001730866 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,500

F1 · shares: These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in its entirety on the earlier of: (i) June 5, 2026 and (ii) the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

Read SEC document
June 05, 2025 Filed Jun 9, 2025 21:47 UTC GrantStock Option (Right to Buy) · Derivative 37,500 $0.00 Strike: $3.51 $0.00
Disclosure

SEC source: 0000950170-25-083907 · ownership.xml · derivative · entry 2

Rothenberg Mace · CIK 0001873988 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 37,500 shares

Expires 2035-06-05

F2 · derivative.exercise_date: This option shall vest and become exercisable in 12 substantially equal monthly installments over a period of one year, with the first vesting date on July 5, 2025, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

Read SEC document
June 05, 2025 Filed Jun 9, 2025 21:47 UTC GrantCommon Stock 6,250 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-083907 · ownership.xml · nonDerivative · entry 1

Rothenberg Mace · CIK 0001873988 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,500

F1 · shares: These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in its entirety on the earlier of: (i) June 5, 2026 and (ii) the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

Read SEC document
June 05, 2025 Filed Jun 9, 2025 21:47 UTC GrantStock Option (Right to Buy) · Derivative 37,500 $0.00 Strike: $3.51 $0.00
Disclosure

SEC source: 0000950170-25-083906 · ownership.xml · derivative · entry 2

Ketchum John B · CIK 0001991806 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 37,500 shares

Expires 2035-06-05

F2 · derivative.exercise_date: This option shall vest and become exercisable in 12 substantially equal monthly installments over a period of one year, with the first vesting date on July 5, 2025, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

Read SEC document
June 05, 2025 Filed Jun 9, 2025 21:47 UTC GrantCommon Stock 6,250 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-083906 · ownership.xml · nonDerivative · entry 1

Ketchum John B · CIK 0001991806 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,937

F1 · shares: These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in its entirety on the earlier of: (i) June 5, 2026 and (ii) the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

Read SEC document
June 05, 2025 Filed Jun 9, 2025 21:45 UTC GrantStock Option (Right to Buy) · Derivative 37,500 $0.00 Strike: $3.51 $0.00
Disclosure

SEC source: 0000950170-25-083903 · ownership.xml · derivative · entry 2

Borisy Alexis · CIK 0001319446 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 37,500 shares

Expires 2035-06-05

F2 · derivative.exercise_date: This option shall vest and become exercisable in 12 substantially equal monthly installments over a period of one year, with the first vesting date on July 5, 2025, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

Read SEC document
June 05, 2025 Filed Jun 9, 2025 21:45 UTC GrantCommon Stock 6,250 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-083903 · ownership.xml · nonDerivative · entry 1

Borisy Alexis · CIK 0001319446 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,500

F1 · shares: These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in its entirety on the earlier of: (i) June 5, 2026 and (ii) the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

Read SEC document
February 05, 2025 Filed Feb 7, 2025 01:21 UTC
Barry DouglasGeneral Counsel
SaleCommon Stock 2,556 $3.16 $8,080.54
Disclosure

SEC source: 0000950170-25-015704 · ownership.xml · nonDerivative · entry 2

Barry Douglas · CIK 0001890662 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,014

F1 · kind: The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $3.00 to $3.245 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

Read SEC document
February 05, 2025 Filed Feb 7, 2025 01:10 UTC
Beckman DaniellaChief Financial Officer
SaleCommon Stock 3,948 $3.16 $12,481.21
Disclosure

SEC source: 0000950170-25-015696 · ownership.xml · nonDerivative · entry 2

Beckman Daniella · CIK 0001513422 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,284

F1 · kind: The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $3.00 to $3.245 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

Read SEC document
February 05, 2025 Filed Feb 7, 2025 01:08 UTC
Crystal AdamSee Remarks
SaleCommon Stock 6,851 $3.16 $21,658.75
Disclosure

SEC source: 0000950170-25-015693 · ownership.xml · nonDerivative · entry 2

Crystal Adam · CIK 0001825445 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 158,210

F1 · kind: The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $3.00 to $3.245 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

Read SEC document
February 05, 2025 Filed Feb 7, 2025 01:02 UTC
Weber BarbaraDirector · Chief Executive Officer
SaleCommon Stock 9,013 $3.16 $28,493.70
Disclosure

SEC source: 0000950170-25-015684 · ownership.xml · nonDerivative · entry 2

Weber Barbara · CIK 0001800670 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,622,251

F1 · kind: The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $3.00 to $3.245 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

Read SEC document
February 04, 2025 Filed Feb 7, 2025 01:21 UTC
Barry DouglasGeneral Counsel
SaleCommon Stock 2,774 $2.99 $8,288.71
Disclosure

SEC source: 0000950170-25-015704 · ownership.xml · nonDerivative · entry 1

Barry Douglas · CIK 0001890662 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,570

F1 · kind: The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $2.86 to $3.07 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

Read SEC document
February 04, 2025 Filed Feb 7, 2025 01:10 UTC
Beckman DaniellaChief Financial Officer
SaleCommon Stock 4,284 $2.99 $12,800.59
Disclosure

SEC source: 0000950170-25-015696 · ownership.xml · nonDerivative · entry 1

Beckman Daniella · CIK 0001513422 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 154,232

F1 · kind: The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $2.86 to $3.07 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

Read SEC document
February 04, 2025 Filed Feb 7, 2025 01:08 UTC
Crystal AdamSee Remarks
SaleCommon Stock 7,432 $2.99 $22,206.82
Disclosure

SEC source: 0000950170-25-015693 · ownership.xml · nonDerivative · entry 1

Crystal Adam · CIK 0001825445 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 165,061

F1 · kind: The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $2.86 to $3.07 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

Read SEC document
February 04, 2025 Filed Feb 7, 2025 01:02 UTC
Weber BarbaraDirector · Chief Executive Officer
SaleCommon Stock 9,778 $2.99 $29,216.66
Disclosure

SEC source: 0000950170-25-015684 · ownership.xml · nonDerivative · entry 1

Weber Barbara · CIK 0001800670 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,631,264

F1 · kind: The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $2.86 to $3.07 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

Read SEC document
February 03, 2025 Filed Feb 6, 2025 00:34 UTC
Crystal AdamSee Remarks
GrantStock Option (Right to Buy) · Derivative 318,090 $0.00 Strike: $2.91 $0.00
Disclosure

SEC source: 0000950170-25-014813 · ownership.xml · derivative · entry 2

Crystal Adam · CIK 0001825445 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 318,090

Underlying: Common Stock · 318,090 shares

Expires 2035-02-03

F2 · derivative.exercise_date: This option shall vest and become exercisable over a four-year period, at a rate of 25% on January 1, 2026, with the remaining option shares vesting in 36 equal monthly installments thereafter.

Read SEC document
February 03, 2025 Filed Feb 6, 2025 00:34 UTC
Crystal AdamSee Remarks
GrantCommon Stock 53,015 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-014813 · ownership.xml · nonDerivative · entry 1

Crystal Adam · CIK 0001825445 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 172,493

F1 · shares: These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest over a three year period at a rate of 33% on February 2, 2026, 33% on February 1, 2027 and 34% on February 14, 2028, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

Read SEC document
February 03, 2025 Filed Feb 6, 2025 00:31 UTC
Weber BarbaraDirector · Chief Executive Officer
GrantStock Option (Right to Buy) · Derivative 635,250 $0.00 Strike: $2.91 $0.00
Disclosure

SEC source: 0000950170-25-014810 · ownership.xml · derivative · entry 2

Weber Barbara · CIK 0001800670 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 635,250

Underlying: Common Stock · 635,250 shares

Expires 2035-02-03

F2 · derivative.exercise_date: This option shall vest and become exercisable over a four-year period, at a rate of 25% on January 1, 2026, with the remaining option shares vesting in 36 equal monthly installments thereafter.

Read SEC document
February 03, 2025 Filed Feb 6, 2025 00:31 UTC
Weber BarbaraDirector · Chief Executive Officer
GrantCommon Stock 105,875 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-014810 · ownership.xml · nonDerivative · entry 1

Weber Barbara · CIK 0001800670 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,641,042

F1 · shares: These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest over a three year period at a rate of 33% on February 2, 2026, 33% on February 1, 2027 and 34% on February 14, 2028, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

Read SEC document
February 03, 2025 Filed Feb 6, 2025 01:14 UTC
Beckman DaniellaChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 156,713 $0.00 Strike: $2.91 $0.00
Disclosure

SEC source: 0000950170-25-014840 · ownership.xml · derivative · entry 2

Beckman Daniella · CIK 0001513422 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 156,713

Underlying: Common Stock · 156,713 shares

Expires 2035-02-03

F2 · derivative.exercise_date: This option shall vest and become exercisable over a four-year period, at a rate of 25% on January 1, 2026, with the remaining option shares vesting in 36 equal monthly installments thereafter.

Read SEC document
February 03, 2025 Filed Feb 6, 2025 01:14 UTC
Beckman DaniellaChief Financial Officer
GrantCommon Stock 26,119 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-014840 · ownership.xml · nonDerivative · entry 1

Beckman Daniella · CIK 0001513422 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 158,516

F1 · shares: These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest over a three year period at a rate of 33% on February 2, 2026, 33% on February 1, 2027 and 34% on February 14, 2028, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

Read SEC document
February 03, 2025 Filed Feb 6, 2025 00:30 UTC
Barry DouglasGeneral Counsel
GrantStock Option (Right to Buy) · Derivative 164,175 $0.00 Strike: $2.91 $0.00
Disclosure

SEC source: 0000950170-25-014808 · ownership.xml · derivative · entry 2

Barry Douglas · CIK 0001890662 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 164,175

Underlying: Common Stock · 164,175 shares

Expires 2035-02-03

F2 · derivative.exercise_date: This option shall vest and become exercisable over a four-year period, at a rate of 25% on January 1, 2026, with the remaining option shares vesting in 36 equal monthly installments thereafter.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.